BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36891308)

  • 21. Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors.
    Meevissen MH; Driessen NN; Smits HH; Versteegh R; van Vliet SJ; van Kooyk Y; Schramm G; Deelder AM; Haas H; Yazdanbakhsh M; Hokke CH
    Int J Parasitol; 2012; 42(3):269-77. PubMed ID: 22673410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
    Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
    Front Immunol; 2018; 9():1132. PubMed ID: 29875777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
    Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
    Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN.
    Chao PZ; Hsieh MS; Cheng CW; Hsu TJ; Lin YT; Lai CH; Liao CC; Chen WY; Leung TK; Lee FP; Lin YF; Chen CH
    Oncotarget; 2015 Jan; 6(1):159-70. PubMed ID: 25402728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor.
    Charles J; Di Domizio J; Salameire D; Bendriss-Vermare N; Aspord C; Muhammad R; Lefebvre C; Plumas J; Leccia MT; Chaperot L
    J Invest Dermatol; 2010 Jun; 130(6):1646-56. PubMed ID: 20220766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells.
    Duinkerken S; Li RE; van Haften FJ; de Gruijl TD; Chiodo F; Schetters STT; van Kooyk Y
    Curr Opin Chem Biol; 2019 Dec; 53():167-172. PubMed ID: 31678713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive Macrophages.
    Lopes N; Correia VG; Palma AS; Brito C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells.
    Wawrzyniak M; Morsy Y; Mladenov R; Tontodonati G; Turgay Y; Herwig S; Back J; Mally M; Faridmoayer A; Scharl M
    J Crohns Colitis; 2021 Sep; 15(9):1596-1601. PubMed ID: 33631789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses.
    Besson S; Laurin D; Chauvière C; Thépaut M; Kleman JP; Pezet M; Manches O; Fieschi F; Aspord C; Fender P
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy.
    Gupta B; Sadaria D; Warrier VU; Kirtonia A; Kant R; Awasthi A; Baligar P; Pal JK; Yuba E; Sethi G; Garg M; Gupta RK
    Semin Cancer Biol; 2022 May; 80():87-106. PubMed ID: 32068087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
    van der Hoorn IAE; Martynova E; Subtil B; Meek J; Verrijp K; Textor J; Flórez-Grau G; Piet B; van den Heuvel MM; de Vries IJM; Gorris MAJ
    Eur J Immunol; 2024 Jan; 54(1):e2350616. PubMed ID: 37840200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity.
    Wolf B; Piksa M; Beley I; Patoux A; Besson T; Cordier V; Voedisch B; Schindler P; Stöllner D; Perrot L; von Gunten S; Brees D; Kammüller M
    Immunology; 2022 Jul; 166(3):380-407. PubMed ID: 35416297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
    J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells.
    Zaal A; Li RJE; Lübbers J; Bruijns SCM; Kalay H; van Kooyk Y; van Vliet SJ
    Front Immunol; 2020; 11():305. PubMed ID: 32161592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.
    Alam MM; Jarvis CM; Hincapie R; McKay CS; Schimer J; Sanhueza CA; Xu K; Diehl RC; Finn MG; Kiessling LL
    ACS Nano; 2021 Jan; 15(1):309-321. PubMed ID: 32790346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.
    Faid V; Evjen G; Tollersrud OK; Michalski JC; Morelle W
    Glycobiology; 2006 May; 16(5):440-61. PubMed ID: 16449350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
    Shu L; Lin S; Zhou S; Yuan T
    Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.